PMID- 29719011 OWN - NLM STAT- MEDLINE DCOM- 20180926 LR - 20220331 IS - 1934-3418 (Electronic) IS - 1078-4519 (Linking) VI - 47 IP - 4 DP - 2018 Apr TI - Short-Term Storage of Platelet-Rich Plasma at Room Temperature Does Not Affect Growth Factor or Catabolic Cytokine Concentration. LID - 10.12788/ajo.2018.0022 [doi] AB - The aim of this study was to provide clinical recommendations about the use of platelet-rich plasma (PRP) that was subjected to short-term storage at room temperature. We determined bioactive growth factor and cytokine concentrations as indicators of platelet and white blood cell degranulation in blood and PRP. Additionally, this study sought to validate the use of manual, direct smear analysis as an alternative to automated methods for platelet quantification in PRP. Blood was used to generate low-leukocyte PRP (Llo PRP) or high-leukocyte PRP (Lhi PRP). Blood was either processed immediately or kept at room temperature for 2 or 4 hours prior to generation of PRP, which was then held at room temperature for 0, 1, 2, or 4 hours. Subsequently, bioactive transforming growth factor beta-1 and matrix metalloproteinase-9 were measured by ELISA (enzyme-linked immunosorbent assay). Manual and automated platelet counts were performed on all blood and PRP samples. There were no differences in growth factor or cytokine concentration when blood or Llo PRP or Lhi PRP was retained at room temperature for up to 4 hours. Manual, direct smear analysis for platelet quantification was not different from the use of automated machine counting for PRP samples, but in the starting blood samples, manual platelet counts were significantly higher than those generated using automated technology. When there is a delay of up to 4 hours in the generation of PRP from blood or in the application of PRP to the patient, bioactive growth factor and cytokine concentrations remain stable in both blood and PRP. A manual direct counting method is a simple, cost-effective, and valid method to measure the contents of the PRP product being delivered to the patient. FAU - Wilson, Brooke H AU - Wilson BH FAU - Cole, Brian J AU - Cole BJ FAU - Goodale, Margaret B AU - Goodale MB FAU - Fortier, Lisa A AU - Fortier LA AD - Department of Clinical Sciences, Cornell University, Ithaca, NY. laf4@cornell.edu. LA - eng PT - Journal Article PL - United States TA - Am J Orthop (Belle Mead NJ) JT - American journal of orthopedics (Belle Mead, N.J.) JID - 9502918 RN - 0 (Cytokines) SB - IM MH - Blood Specimen Collection/*methods MH - Cytokines/blood MH - Humans MH - *Platelet-Rich Plasma MH - *Temperature COIS- Authors' Disclosure Statement: The authors report that Arthrex donated syringes for generating platelet-rich plasma. Dr. Fortier reports that she is a paid consultant for Arthrex. Dr. Cole reports that he receives intellectual property royalties from, is a paid consultant, and provides research support to Arthrex. This article was supported by the National Institute of Health and the Harry M. Zweig Memorial Fund for Equine Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. EDAT- 2018/05/03 06:00 MHDA- 2018/09/27 06:00 CRDT- 2018/05/03 06:00 PHST- 2018/05/03 06:00 [entrez] PHST- 2018/05/03 06:00 [pubmed] PHST- 2018/09/27 06:00 [medline] AID - 10.12788/ajo.2018.0022 [doi] PST - ppublish SO - Am J Orthop (Belle Mead NJ). 2018 Apr;47(4). doi: 10.12788/ajo.2018.0022.